rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lawrence P. Guiheen

Director

Company insider

Files Form 4 as: Director, ADMA Biologics.

Every Form 4 they filed

In numbers

Trades disclosed
47
Buys
5
Sells
4
Bought
$316K
Sold
$768K
Companies
1
Companies where not an officer
1
First trade
17 Jul 2012
Last trade
17 Mar 2026
Last filed
17 Mar 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ADMA ADMA BiologicsDirector · Biotechnology · last 17 Mar 20265 buys · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Mar 2026filed 17 Mar 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code G—30,000 at $0.00filing
17 Mar 2026filed 17 Mar 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code G—30,000 at $0.00filing
17 Mar 2026filed 17 Mar 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code G—30,000 at $0.00filing
17 Mar 2026filed 17 Mar 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code G—30,000 at $0.00filing
13 Mar 2026filed 17 Mar 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code M$110K30,000 at $3.66filing
13 Mar 2026filed 17 Mar 2026ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code M—30,000 at $0.00filing
13 Mar 2026filed 17 Mar 2026ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code M—30,000 at $0.00filing
13 Mar 2026filed 17 Mar 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code M$110K30,000 at $3.66filing
9 Feb 2026filed 11 Feb 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code A—10,690 at $0.00filing
9 Feb 2026filed 11 Feb 2026ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code A—17,730 at $0.00filing
9 Feb 2026filed 11 Feb 2026ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code A—17,730 at $0.00filing
9 Feb 2026filed 11 Feb 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code A—10,690 at $0.00filing
9 Jun 2025filed 11 Jun 2025ADMA ADMA BiologicsBiotechnologySEC FORM 4 Sold$419K20,000 at $20.96filing
22 May 2025filed 23 May 2025ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code M—1,221 at $0.00filing
22 May 2025filed 23 May 2025ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code M$7,2771,221 at $5.96filing
22 May 2025filed 23 May 2025ADMA ADMA BiologicsBiotechnologySEC FORM 4 Sold$25K1,221 at $20.12filing
21 May 2025filed 23 May 2025ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code M—7,779 at $0.00filing
21 May 2025filed 23 May 2025ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code M$46K7,779 at $5.96filing
21 May 2025filed 23 May 2025ADMA ADMA BiologicsBiotechnologySEC FORM 4 Sold$158K7,779 at $20.32filing
19 Feb 2025filed 21 Feb 2025ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code A—16,279 at $0.00filing

News

Arcturus Therapeutics (NASDAQ:ARCT) & ADMA Biologics (NASDAQ:ADMA) Head-To-Head SurveyADMA · dailypolitical.com · 18 Oct 2026Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ADMA · dailypolitical.com · 13 Oct 2026

0 headlines in the last 90 days name Lawrence P. Guiheen; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care9

Buys in green, sells in red, by the company’s sector.

Related people

Kaitlin M. Kestenberg-MessinaCOO and SVP, Compliance · COO and SVP, Compliance at Adma Biologics, filing Form 4 there in the last year
Terry KohlerCFO and Treasurer · CFO and Treasurer at Adma Biologics, filing Form 4 there in the last year
Jerrold B. GrossmanDirector · Director at Adma Biologics, filing Form 4 there in the last year
Adam S. GrossmanPresident and CEO · President and CEO at Adma Biologics, filing Form 4 there in the last year
Steve ElmsDirector · Director at Adma Biologics, filing Form 4 there in the last year
Donald J. TrumpPresident · Also traded ADMA in the last 90 days